See what a validation package looks like when it builds itself
A short walkthrough of how GxPForge keeps traceability current as your team works, instead of reconstructing it before a release.
Book a demoA small biotech often handles its first validated system fine, one product, one careful team, close attention. The mistakes tend to show up once the company scales, more systems, more people, and validation processes that were never designed to run at that pace.
Early on, a company might validate its first LIMS with real care, a dedicated project, thorough documentation. The mistake is not building a repeatable process out of that first effort. By the fifth system, without a template or standard approach, each validation starts from scratch, and quality becomes inconsistent depending on who happens to be running it that quarter.
As headcount grows, it becomes less clear who is actually responsible for keeping a given system's validation status current. A system validated by someone who has since left the company, with no clear owner since, is a common finding in a growing biotech's first serious audit.
A company that starts with three systems can easily be managing fifteen within a couple of years, as new tools get adopted by different teams. Without a process for catching new GxP relevant systems as they get adopted, some of them end up in production, unvalidated, simply because nobody flagged them in time.
A short walkthrough of how GxPForge keeps traceability current as your team works, instead of reconstructing it before a release.
Book a demo